A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck

被引：0
|
作者：
Taylor, Matthew H. [1 ]
Rasco, Drew W. [2 ]
Brose, Marcia S. [3 ]
Vogelzang, Nicholas J. [4 ]
Richey, Stephen L. [4 ]
Cohen, Allen L. [4 ]
Richards, Donald A. [4 ]
Stepan, Daniel E. [5 ]
Dutcus, Corina E. [5 ]
Guo, Matthew [5 ]
Shumaker, Robert C. [5 ]
Schmidt, Emmett V. [6 ]
Young, Louise [7 ]
Wirth, Lori J. [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[2] South Texas Accelerated Res Therapeut, San Antonio, TX USA
[3] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[4] McKesson Specialty Hlth, US Oncol Network, Ft Worth, TX USA
[5] Eisai Inc, Woodcliff Lake, NJ USA
[6] Merck & Co Inc, Kenilworth, NJ USA
[7] Eisai Australia Pty Ltd, Melbourne, Vic, Australia
[8] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
366
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [41] A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
    David G. Pfister
    John McCaffrey
    Andrew J. Zahalsky
    Gary K. Schwartz
    Eric Lis
    William Gerald
    Andrew Huvos
    Jatin Shah
    Dennis Kraus
    Ashok Shaha
    Bhuvanesh Singh
    Suzanne Wolden
    Michael Zelefsky
    Ilana Palgi
    [J]. Investigational New Drugs, 2002, 20 : 123 - 127
  • [42] Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial
    Hsieh, Ching-Yun
    Lien, Ming-Yu
    Lin, Chen-Yuan
    Lo, Wen-Jyi
    Hua, Chung-Hung
    Chang, Wei-Chao
    Chiu, Chang-Fang
    Lin, Ching-Chan
    [J]. BMC CANCER, 2022, 22 (01)
  • [43] Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
    Lee, Chung-Han
    Shah, Amishi Yogesh
    Rasco, Drew
    Rao, Arpit
    Taylor, H. Matthew
    Di Simone, Christopher
    Hsieh, J. James
    Pinto, Alvaro
    Shaffer, R. David
    Sarrio, Regina Girones
    Cohn, Allen Lee
    Vogelzang, J. Nicholas
    Bilen, Mehmet Asim
    Ribe, Sara Gunnestad
    Goksel, Musaberk
    Tennoe, Oyvind Krohn
    Richards, Donald
    Sweis, F. Randy
    Courtright, Jay
    Heinrich, Daniel
    Jain, Sharad
    Wu, Jane
    Schmidt, V. Emmett
    Perini, F. Rodolfo
    Kubiak, Peter
    Okpara, E. Chinyere
    Smith, D. Alan
    Motzer, J. Robert
    [J]. LANCET ONCOLOGY, 2021, 22 (07): : 946 - 958
  • [44] A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Kochanny, Sara E.
    Worden, Francis P.
    Adkins, Douglas R.
    Lim, Dean W.
    Bauman, Julie E.
    Wagner, Stephanie A.
    Brisson, Ryan J.
    Karrison, Theodore G.
    Stadler, Walter M.
    Vokes, Everett E.
    Seiwert, Tanguy Y.
    [J]. CANCER, 2020, 126 (10) : 2146 - 2152
  • [45] Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial
    Ching-Yun Hsieh
    Ming-Yu Lien
    Chen-Yuan Lin
    Wen-Jyi Lo
    Chung-Hung Hua
    Wei-Chao Chang
    Chang-Fang Chiu
    Ching-Chan Lin
    [J]. BMC Cancer, 22
  • [46] Cortactin and coronin 1B cooperate to promote tumor cell invasion in head and neck squamous cell carcinoma
    Walk, Elyse L.
    Wu, Hong
    Garcia, Marileila V.
    Bear, James E.
    Weed, Scott A.
    [J]. CANCER RESEARCH, 2011, 71
  • [47] Phase 1b/2 trial of tucatinib plus trastuzumab plus /-chemotherapy or pembrolizumab in patients with metastatic HER2+GI cancers
    Shitara, Kohei
    Park, Haeseong
    Bekaii-Saab, Tanios
    Kim, Sunnie S.
    Kamath, Suneel
    Pishvaian, Michael J.
    Chen, Christopher
    Zhen, David B.
    Mayor, Joal
    Tan, Qianwen
    Strickler, John H.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S502 - S502
  • [48] PHASE-2 TRIAL OF ADRIAMYCIN AND METRONIDAZOLE IN PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    CRIPPS, MC
    STEWART, D
    MAROUN, J
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 1986, 9 (03): : A127 - A127
  • [49] Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
    Sacco, Assuntina G.
    Chen, Ruifeng
    Worden, Francis P.
    Wong, Deborah J. L.
    Adkins, Douglas
    Swiecicki, Paul
    Chai-Ho, Wanxing
    Oppelt, Peter
    Ghosh, Debanjali
    Bykowski, Julie
    Molinolo, Alfredo
    Pittman, Emily
    Estrada, M. Valeria
    Gold, Kathryn
    Daniels, Gregory
    Lippman, Scott M.
    Natsuhara, Amanda
    Messer, Karen
    Cohen, Ezra E. W.
    [J]. LANCET ONCOLOGY, 2021, 22 (06): : 883 - 892
  • [50] Molecular screening and early phase trial inclusion for head and neck squamous cell carcinoma patients
    Vozy, A.
    Roussel-Simonin, C.
    Houessinon, A.
    Bayle, A.
    Blanc-Durand, F.
    Ferrand, F. R.
    Fouilloux, A.
    Iacob, M.
    Khalife, N.
    Ponce, S.
    Loriot, Y.
    Baldini, C.
    Italiano, A.
    Even, C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (08) : S1423 - S1424
12345